Article

Comparing Post-Grant Procedures at the USPTO, EPO and JPO

The USPTO offers post-grant review, inter partes review and ex parte reexamination; the European Patent Office offers a central opposition within nine months of the mention of grant; and the Japan Patent Office offers an opposition within six months of gazette publication plus invalidation trials at any time. They differ in timing, who may file, available grounds and effect.

On this page
  1. United States: PGR, IPR and ex parte reexamination
  2. European Patent Office: opposition
  3. Japan Patent Office: opposition and invalidation trials
  4. Side-by-side comparison
  5. Coordinating challenges across offices
  6. Key takeaways

Companies with global portfolios often face the same invention in patents granted by several offices. Each major office provides a way to challenge a granted patent administratively, without going to court. The U.S. Patent and Trademark Office, the European Patent Office (EPO) and the Japan Patent Office (JPO) take different approaches, and the differences in timing, available grounds and legal effect affect how parties coordinate their challenges.

This page gives a high-level comparison. Details of foreign procedure, fees and deadlines should be confirmed with the relevant office.

United States: PGR, IPR and ex parte reexamination

The USPTO has three main post-grant tools for third parties.

  • Post-grant review (PGR) must be filed within nine months of grant and is available only for patents with an effective filing date on or after March 16, 2013. It allows most invalidity grounds, including §§ 101, 102, 103 and 112. See the post-grant review guide.
  • Inter partes review (IPR) may be filed after the nine-month PGR window, or after any PGR ends. It is limited to §§ 102 and 103 based on patents and printed publications, and it is subject to a one-year bar if the petitioner was served with an infringement complaint. See the inter partes review guide.
  • Ex parte reexamination may be requested by anyone, including the patent owner, at any time during the period of enforceability, based on a substantial new question of patentability raised by patents or printed publications. After the order, the proceeding is conducted between the Office and the patent owner. See the ex parte reexamination guide.

PGR and IPR are trials before the Patent Trial and Appeal Board, with limited discovery and a final written decision, and both carry estoppel. Reexamination is handled by examiners in the Central Reexamination Unit.

European Patent Office: opposition

A European patent may be opposed at the EPO within nine months of publication of the mention of grant in the European Patent Bulletin (Art. 99 EPC). Any person other than the proprietor may file, and the opposition fee must be paid within the same period.

The grounds are set out in Art. 100 EPC:

  • The subject matter is not patentable under Arts. 52 to 57 EPC, which covers novelty, inventive step, industrial application and excluded subject matter
  • The patent does not disclose the invention clearly and completely enough for a skilled person to carry it out
  • The subject matter extends beyond the content of the application as filed

The opposition is decided by an opposition division. Its decision may be appealed to the Boards of Appeal. The outcome is that the patent is revoked, the opposition is rejected, or the patent is maintained in amended form, and that result applies centrally for all states in which the patent has effect (Art. 101 EPC). After the opposition period, challenges generally move to national courts or, for participating states, the Unified Patent Court.

Japan Patent Office: opposition and invalidation trials

Japan reintroduced a post-grant opposition system in 2015. An opposition may be filed within six months of publication of the patent gazette. It is decided by a panel at the JPO and is designed as a comparatively streamlined route for third parties to ask the Office to reconsider a recent grant.

Separately, Japan provides invalidation trials, which may be requested by an interested party at any time. Invalidation trials are adversarial and are commonly used alongside infringement disputes. Both procedures are handled within the JPO’s trial and appeal system, and decisions can be challenged in the courts.

Side-by-side comparison

USPTO PGRUSPTO IPRUSPTO ex parte reexamEPO oppositionJPO oppositionJPO invalidation trial
TimingWithin 9 months of grantAfter the 9-month window; one-year bar if suedAny time during enforceabilityWithin 9 months of mention of grantWithin 6 months of gazette publicationAny time
Who can fileAnyone but the patent ownerAnyone but the patent ownerAnyone, including the ownerAnyone but the proprietorThird partiesInterested parties
GroundsMost invalidity grounds, incl. §§ 101, 112§§ 102, 103 on patents and printed publicationsPatents and printed publicationsArt. 100 EPCStatutory grounds, broadly patentability-basedStatutory grounds
Decision-makerPTAB panelPTAB panelExaminer (CRU)Opposition divisionJPO panelJPO panel
EffectClaims canceled or confirmed; estoppelClaims canceled or confirmed; estoppelClaims canceled, confirmed or amendedRevoked, maintained or amended for all designated statesRevoked or maintainedInvalidated or upheld

For a broader chart of U.S. options, see the PGR comparison chart.

Coordinating challenges across offices

A few practical points follow from the comparison:

  • Early windows overlap. The EPO and U.S. PGR windows are both nine months, and the JPO window is six, so a party monitoring competitors’ patents may need to decide early about parallel challenges.
  • Grounds differ. Arguments based on added matter or sufficiency at the EPO have counterparts in U.S. written description and enablement, which are available in PGR but not IPR.
  • Effects differ. An EPO decision acts centrally across designated states, while U.S. and Japanese decisions affect only the national patent.
  • Positions travel. Arguments and amendments made in one office may be cited in another. Consistency across proceedings matters.

For the U.S. comparison in more detail, see PGR vs. IPR.

Key takeaways

  • The USPTO offers PGR (nine months), IPR (after nine months) and ex parte reexamination (any time).
  • EPO opposition must be filed within nine months of the mention of grant, by anyone but the proprietor, on Art. 100 EPC grounds, and acts centrally.
  • The JPO offers an opposition within six months of gazette publication, reintroduced in 2015, and invalidation trials available at any time to interested parties.
  • Timing, grounds and effect differ enough that global challenges need coordination.

Frequently Asked Questions

Is a European opposition like a U.S. post-grant review?

They are similar in timing and breadth: both must be filed within nine months and both allow broad grounds. The main differences are that the EPO decision applies across all designated states and that EPO opposition grounds are set by Article 100 EPC rather than U.S. statutes.

Can a patent owner oppose its own European patent?

No. An opposition may be filed by any person other than the proprietor. A proprietor wanting to narrow or revoke its own European patent can use the separate central limitation or revocation procedure.

Primary Sources

  1. 35 U.S.C. §§ 321–329 (post-grant review)
  2. 35 U.S.C. §§ 311–319 (inter partes review)
  3. 35 U.S.C. §§ 301–307 (ex parte reexamination)
  4. European Patent Convention (Articles 99–101)
  5. Japan Patent Office

Educational information; not legal advice. Statutes, rules and USPTO practice change. Confirm against the primary sources and consult a registered patent practitioner before acting. Disclaimer.